- Home
- WHLR vs REVB Comparison
WHLR vs REVB Comparison
Compare WHLR & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- REVB
- Stock Information
- Founded
- WHLR 2011
- REVB 2020
- Country
- WHLR United States
- REVB United States
- Employees
- WHLR N/A
- REVB N/A
- Industry
- WHLR Real Estate Investment Trusts
- REVB Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- REVB Health Care
- Exchange
- WHLR Nasdaq
- REVB Nasdaq
- Market Cap
- WHLR 4.2M
- REVB 4.4M
- IPO Year
- WHLR 2012
- REVB N/A
- Fundamental
- Price
- WHLR $2.26
- REVB $1.55
- Analyst Decision
- WHLR
- REVB
- Analyst Count
- WHLR 0
- REVB 0
- Target Price
- WHLR N/A
- REVB N/A
- AVG Volume (30 Days)
- WHLR 4.5M
- REVB 874.0K
- Earning Date
- WHLR 11-06-2025
- REVB 11-07-2025
- Dividend Yield
- WHLR N/A
- REVB N/A
- EPS Growth
- WHLR N/A
- REVB N/A
- EPS
- WHLR N/A
- REVB N/A
- Revenue
- WHLR $102,799,000.00
- REVB N/A
- Revenue This Year
- WHLR N/A
- REVB N/A
- Revenue Next Year
- WHLR N/A
- REVB N/A
- P/E Ratio
- WHLR N/A
- REVB N/A
- Revenue Growth
- WHLR N/A
- REVB N/A
- 52 Week Low
- WHLR $1.50
- REVB $1.50
- 52 Week High
- WHLR $8,593.20
- REVB $60.48
- Technical
- Relative Strength Index (RSI)
- WHLR 49.83
- REVB 41.42
- Support Level
- WHLR $1.86
- REVB N/A
- Resistance Level
- WHLR $2.59
- REVB $2.90
- Average True Range (ATR)
- WHLR 0.30
- REVB 0.19
- MACD
- WHLR 0.15
- REVB -0.19
- Stochastic Oscillator
- WHLR 68.35
- REVB 53.50
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).